---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-055725"
form_type: "8-K"
ticker: "DERM"
cik: "0001867066"
company_name: "Journey Medical Corp"
filed_at: "2024-05-01T23:59:59+00:00"
generated_at: "2026-06-03T03:16:16.610414+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Journey Medical appoints Joseph Benesch as permanent CFO effective April 26

## Summary
- Mr. Benesch had served as interim CFO since January 2023 and as Corporate Controller since November 2021.
- Compensation remains unchanged; any future changes will be determined by Board/Compensation Committee.
- Benesch brings over 25 years of public/private accounting and life sciences experience, including prior CFO roles at Teligent and Torrent.
- CEO Claude Maraoui cited Benesch's leadership as key for upcoming milestones, including potential DFD-29 FDA decision for rosacea.

## SEC filing metadata
- accession: 0001104659-24-055725
- form_type: 8-K
- ticker: DERM
- cik: 0001867066
- company_name: Journey Medical Corp
- filed_at: 2024-05-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867066/000110465924055725/0001104659-24-055725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867066/000110465924055725/tm2413228d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-055725
- JSON: https://secwatch.observer/filing/0001104659-24-055725.json
- Plain text: https://secwatch.observer/filing/0001104659-24-055725.txt

## Key facts
- Executive change
  Joseph Benesch was appointed as Chief Financial Officer at Journey Medical Corp.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On April 26, 2024, the Board of Directors (the “ Board ”) of Journey Medical Corporation (the “ Company ”) appointed Joseph Benesch, age 57, as the Company’s permanent Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1867066/000110465924055725/0001104659-24-055725-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.